一种新型的三层勒沃多巴-卡比多巴胃药片,用于改善勒沃多巴的药理动力学
Xiangcheng Zhao1, Peng Yan1, Hailong Zhang2
1Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan 410006, China.
概括
一种新的胃养性卡比多巴-莱沃多巴片通过维持稳定的药物水平12小时来改善帕金森病的治疗,为患者提供了更方便的选择.
科学领域:
- 制药科学 制药科学
- 药物输送系统 药物输送系统
- 神经退行性疾病 神经退行性疾病
背景情况:
- 帕金森病 (PD) 治疗面临挑战,原因是勒沃多巴的吸收狭窄和外周脱碳酶的影响.
- 维持稳定的勒沃多巴血度对于有效的PD管理至关重要.
研究的目的:
- 为改善PD治疗设计和评估一种新的胃补充性卡比多巴-莱沃多巴三层药片.
- 为了提高levodopa的药理动力学特征和作用持续时间.
主要方法:
- 开发一种具有扩张,即时释放和持续释放组件的三层平板电脑.
- 在 beagle 模型中评估胃保留特性.
- 在食条件下进行的药理动力学研究,以评估药物释放和血度.
主要成果:
- 设计的药片表现出优异的胃保留超过10小时.
- 药理动力学数据显示,与Sinemet® CR相比,疗效持续时间显著优越.
- 有效的勒沃多巴血水平维持了长达12小时.
结论:
- 新型胃缩性卡比多巴-莱沃多巴片显示了长时间和稳定的药物释放.
- 这种配方为帕金森病患者提供了一个有希望的,更方便的治疗选择.
- 改善药物输送解决了目前基于利沃多巴的PD治疗方法的关键局限性.
相关概念视频
Parkinson's Disease: Treatment
206
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
206
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.0K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.0K
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
249
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
249
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
908
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
908
Depolarizing Blockers: Pharmocokinetics
305
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
305
Prodrugs
2.4K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.4K


